Evogene establishes LaVie Bio Ltd.


Evogene Ltd. has established a new subsidiary – LaVie Bio Ltd. The new company will focus on improving food quality, agriculture sustainability and productivity through the introduction of novel microbiome based ag-biological products.

EvogeneEvogene’s ag-biological assets, capabilities and pipeline focusing on the discovery, optimization and development of sustainable ag-biological products are being transferred to the new subsidiary, along with access to Evogene’s Computational Predictive Biology (CPB) platform. In addition, Evogene’s existing co-development collaboration with Corteva, the agricultural division of DowDuPont, in the field of corn biostimulants, will be transferred to LaVie. The assets and capabilities being transferred to LaVie are a result of Evogene’s ag-biologicals division’s activity initiated in 2015, and include a substantial pipeline focusing on biostimulant and biopesticide product programs.

LaVie’s senior management consists of the previous division managers with Ido Dor, previously the ag-biologicals division General Manager and Evogene EVP, now appointed as LaVie Chief Executive Officer. Ofer Haviv, Evogene’s CEO, will serve as chairman of the board of directors of the new subsidiary.

More information

News From Suppliers